Paolo Moi

4.5k total citations · 1 hit paper
60 papers, 2.9k citations indexed

About

Paolo Moi is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Paolo Moi has authored 60 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Genetics, 31 papers in Molecular Biology and 22 papers in Hematology. Recurrent topics in Paolo Moi's work include Hemoglobinopathies and Related Disorders (34 papers), Iron Metabolism and Disorders (18 papers) and Epigenetics and DNA Methylation (8 papers). Paolo Moi is often cited by papers focused on Hemoglobinopathies and Related Disorders (34 papers), Iron Metabolism and Disorders (18 papers) and Epigenetics and DNA Methylation (8 papers). Paolo Moi collaborates with scholars based in Italy, United States and United Kingdom. Paolo Moi's co-authors include Antonio Cao, Yuet Wai Kan, Isadora Asunis, Anthony Chan, Mario Pirastu, Y Kan, M. Marini, R. Galanello, E. Paglietti and Renzo Galanello and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Paolo Moi

60 papers receiving 2.8k citations

Hit Papers

Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like ... 1994 2026 2004 2015 1994 400 800 1.2k

Peers

Paolo Moi
P D Berk United States
Heidi S. Camp United States
Harry S. Margolius United States
Colin A. Flaveny United States
Shivendra D. Shukla United States
A K Hajra United States
Kang Ho Kim United States
P D Berk United States
Paolo Moi
Citations per year, relative to Paolo Moi Paolo Moi (= 1×) peers P D Berk

Countries citing papers authored by Paolo Moi

Since Specialization
Citations

This map shows the geographic impact of Paolo Moi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Moi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Moi more than expected).

Fields of papers citing papers by Paolo Moi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Moi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Moi. The network helps show where Paolo Moi may publish in the future.

Co-authorship network of co-authors of Paolo Moi

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Moi. A scholar is included among the top collaborators of Paolo Moi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Moi. Paolo Moi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maggio, Fabio, et al.. (2024). Unmanned Ground Vehicles for Continuous Crop Monitoring in Agriculture: Assessing the Readiness of Current ICT Technology. Machines. 12(11). 750–750. 11 indexed citations
2.
Pala, Mauro, Isadora Asunis, Lucia Perseu, et al.. (2023). miR-365-3p mediates BCL11A and SOX6 erythroid-specific coregulation: A new player in HbF activation. Molecular Therapy — Nucleic Acids. 34. 102025–102025. 1 indexed citations
3.
Alesi, Viola, et al.. (2021). A New Intronic Variant in ECEL1 in Two Patients with Distal Arthrogryposis Type 5D. International Journal of Molecular Sciences. 22(4). 2106–2106. 4 indexed citations
4.
Ye, Lin, Isadora Asunis, Maria Franca Marongiu, et al.. (2020). Induction of therapeutic levels of HbF in genome‐edited primary β039‐thalassaemia haematopoietic stem and progenitor cells. British Journal of Haematology. 192(2). 395–404. 13 indexed citations
5.
Fugazza, Cristina, M. Marini, Maria Franca Marongiu, et al.. (2020). The Coup-TFII orphan nuclear receptor is an activator of the γ-globin gene. Haematologica. 106(2). 474–482. 7 indexed citations
6.
Origa, Raffaella, Susanna Barella, Franco Anni, et al.. (2017). Hematological phenotypes in children according to the α-globin genotypes. Blood Cells Molecules and Diseases. 69. 102–106. 4 indexed citations
7.
Satta, Stefania, et al.. (2017). Changes in HbA2 and HbF in alpha thalassemia carriers with KLF1 mutation. Blood Cells Molecules and Diseases. 64. 30–32. 6 indexed citations
8.
Marongiu, Maria Franca, Carla Casu, R. Galanello, et al.. (2013). In vivo activation of the human  -globin gene: the therapeutic potential in  -thalassemic mice. Haematologica. 99(1). 76–84. 20 indexed citations
9.
Porcu, Susanna, Maria Franca Marongiu, Valeria Sogos, et al.. (2011). Klf1 Affects DNase II-Alpha Expression in the Central Macrophage of a Fetal Liver Erythroblastic Island: a Non-Cell-Autonomous Role in Definitive Erythropoiesis. Molecular and Cellular Biology. 31(19). 4144–4154. 36 indexed citations
10.
Cao, Antonio, Paolo Moi, & Renzo Galanello. (2011). Recent Advances in β-Thalassemias. SHILAP Revista de lepidopterología. 3(2). e17–e17. 33 indexed citations
11.
Marini, M., Isadora Asunis, Maria Serafina Ristaldi, et al.. (2010). Regulation of the humanHBAgenes by KLF4 in erythroid cell lines. British Journal of Haematology. 149(5). 748–758. 13 indexed citations
12.
Sadelain, Michel, et al.. (2008). Stem Cell Engineering for the Treatment of Severe Hemoglobinopathies. Current Molecular Medicine. 8(7). 690–697. 20 indexed citations
13.
Inoue, Akio, et al.. (2004). Negative regulation of γ-globin gene expression by cyclic AMP-dependent pathway in erythroid cells. Experimental Hematology. 32(3). 244–253. 28 indexed citations
14.
Moi, Paolo, V. Faà, M. Marini, et al.. (2004). A novel silent β‐thalassemia mutation in the distal CACCC box affects the binding and responsiveness to EKLF. British Journal of Haematology. 126(6). 881–884. 30 indexed citations
15.
Marini, M., Isadora Asunis, Kaimin Chan, et al.. (2002). Cloning MafF by Recognition Site Screening with the NFE2 Tandem Repeat of HS2: Analysis of Its Role in Globin and GCSl Genes Regulation. Blood Cells Molecules and Diseases. 29(2). 145–158. 17 indexed citations
16.
Catani, Lucia, Nicola Vianelli, Marilina Amabile, et al.. (2002). Nuclear factor-erythroid 2 (NF-E2) expression in normal and malignant megakaryocytopoiesis. Leukemia. 16(9). 1773–1781. 11 indexed citations
17.
Moroni, Emanuela, et al.. (2000). Regulation of Mouse p45 NF-E2 Transcription by an Erythroid-specific GATA-dependent Intronic Alternative Promoter. Journal of Biological Chemistry. 275(14). 10567–10576. 22 indexed citations
18.
Meloni, Antonella, et al.. (1996). A missense (T577I) mutation in the luteinizing hormone receptor gene associated with familial male-limited precocious puberty. Human Mutation. 7(2). 164–166. 15 indexed citations
19.
Murru, S, Lucia Casarino, Paolo Moi, et al.. (1994). A DNA Fragment from Xq21 Replaces a Deleted Region Containing the Entire FVIII Gene in a Severe Hemophilia A Patient. Genomics. 23(2). 352–361. 2 indexed citations
20.
Pirastu, Mario, et al.. (1987). Molecular characterization of a normal Hb A2β‐thalassaemia determinant in a Sardinian family. British Journal of Haematology. 67(2). 225–229. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026